Response to commentary by Grifell and Hart, commentary on: The problem of mephedrone in Europe: Causes and suggested solutions

Eur Psychiatry. 2019 Jan:55:123-124. doi: 10.1016/j.eurpsy.2018.11.006. Epub 2018 Nov 28.

Authors

M Ordak¹, T Nasierowski²

Affiliations

¹ Department of Pharmacodynamics, Centre for Preclinical Research and Technology (CePT), Medical University of Warsaw, St. Banacha 1B, 02-097 Warsaw, Poland. Electronic address: mordak@wum.edu.pl.
² Department of Psychiatry, Medical University of Warsaw, Poland.

PMID: 30500559
DOI: 10.1016/j.eurpsy.2018.11.006

No abstract available

Publication types

Editorial
Comment